Cargando…
Accurate personalized survival prediction for amyotrophic lateral sclerosis patients
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Accurately predicting the survival time for ALS patients can help patients and clinicians to plan for future treatment and care. We describe the application of a machine-learned tool that incorporates clinical fe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673879/ https://www.ncbi.nlm.nih.gov/pubmed/38001260 http://dx.doi.org/10.1038/s41598-023-47935-7 |
_version_ | 1785149650882265088 |
---|---|
author | Kuan, Li-Hao Parnianpour, Pedram Kushol, Rafsanjany Kumar, Neeraj Anand, Tanushka Kalra, Sanjay Greiner, Russell |
author_facet | Kuan, Li-Hao Parnianpour, Pedram Kushol, Rafsanjany Kumar, Neeraj Anand, Tanushka Kalra, Sanjay Greiner, Russell |
author_sort | Kuan, Li-Hao |
collection | PubMed |
description | Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Accurately predicting the survival time for ALS patients can help patients and clinicians to plan for future treatment and care. We describe the application of a machine-learned tool that incorporates clinical features and cortical thickness from brain magnetic resonance (MR) images to estimate the time until a composite respiratory failure event for ALS patients, and presents the prediction as individual survival distributions (ISDs). These ISDs provide the probability of survival (none of the respiratory failures) at multiple future time points, for each individual patient. Our learner considers several survival prediction models, and selects the best model to provide predictions. We evaluate our learned model using the mean absolute error margin (MAE-margin), a modified version of mean absolute error that handles data with censored outcomes. We show that our tool can provide helpful information for patients and clinicians in planning future treatment. |
format | Online Article Text |
id | pubmed-10673879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106738792023-11-24 Accurate personalized survival prediction for amyotrophic lateral sclerosis patients Kuan, Li-Hao Parnianpour, Pedram Kushol, Rafsanjany Kumar, Neeraj Anand, Tanushka Kalra, Sanjay Greiner, Russell Sci Rep Article Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Accurately predicting the survival time for ALS patients can help patients and clinicians to plan for future treatment and care. We describe the application of a machine-learned tool that incorporates clinical features and cortical thickness from brain magnetic resonance (MR) images to estimate the time until a composite respiratory failure event for ALS patients, and presents the prediction as individual survival distributions (ISDs). These ISDs provide the probability of survival (none of the respiratory failures) at multiple future time points, for each individual patient. Our learner considers several survival prediction models, and selects the best model to provide predictions. We evaluate our learned model using the mean absolute error margin (MAE-margin), a modified version of mean absolute error that handles data with censored outcomes. We show that our tool can provide helpful information for patients and clinicians in planning future treatment. Nature Publishing Group UK 2023-11-24 /pmc/articles/PMC10673879/ /pubmed/38001260 http://dx.doi.org/10.1038/s41598-023-47935-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kuan, Li-Hao Parnianpour, Pedram Kushol, Rafsanjany Kumar, Neeraj Anand, Tanushka Kalra, Sanjay Greiner, Russell Accurate personalized survival prediction for amyotrophic lateral sclerosis patients |
title | Accurate personalized survival prediction for amyotrophic lateral sclerosis patients |
title_full | Accurate personalized survival prediction for amyotrophic lateral sclerosis patients |
title_fullStr | Accurate personalized survival prediction for amyotrophic lateral sclerosis patients |
title_full_unstemmed | Accurate personalized survival prediction for amyotrophic lateral sclerosis patients |
title_short | Accurate personalized survival prediction for amyotrophic lateral sclerosis patients |
title_sort | accurate personalized survival prediction for amyotrophic lateral sclerosis patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673879/ https://www.ncbi.nlm.nih.gov/pubmed/38001260 http://dx.doi.org/10.1038/s41598-023-47935-7 |
work_keys_str_mv | AT kuanlihao accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients AT parnianpourpedram accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients AT kusholrafsanjany accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients AT kumarneeraj accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients AT anandtanushka accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients AT kalrasanjay accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients AT greinerrussell accuratepersonalizedsurvivalpredictionforamyotrophiclateralsclerosispatients |